Relmada Therapeutics Inc RLMD
NASDAQ · United States · Health Technology
$3.60-0.06 (-1.64%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.11 | -0.20 | +44.9% | $0 | — | -9.2%$5.44→$4.94 |
| Q1 2026 | 2026-05-12 | -0.22 | -0.18 | -22.2% | — | — | +1.8%$7.36→$7.49 |
| Q4 2025 | 2026-03-19 | -0.29 | -0.14 | -107.1% | — | — | -2.3%$6.21→$6.07 |
| Q3 2025 | 2025-11-13 | -0.30 | -0.04 | -650.0% | — | — | +1.0%$3.91→$3.95 |
| Q4 2024 | 2025-03-27 | -0.62 | -0.70 | +11.4% | — | — | — |
| Q4 2023 | 2024-03-19 | -0.84 | -0.83 | -1.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.